• Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
Tuesday, March 28, 2023
No Result
View All Result
SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home Business

Gland Pharma, Yes Bank shares may become large-caps; AMFI may reclassify these stocks in January

by The Outlooker Web Desk
December 28, 2020
in Business
0
Stocks in focus: Reliance Communications, HDFC Bank, State Bank of India, UltraTech Cement, IndiGo
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

Stocks that may be reclassified as midcaps from the current smallcap category include those that have recently gained significantly.

Recent Dalal Street debutant Gland Pharma could be among the stocks to be reclassified as large-cap stocks in the semi-annual review by Association of Mutual Funds in India (AMFI). Brokerage and research firm Edelweiss has forecasted Gland Pharma along with Yes Bank, Jubilant FoodWorks among others to be among the stocks that will be reclassified as large-caps in the semi-annual AMFI review later next month. The review will take into account the performance of the stocks available till the end of 2020 and with just a handful of sessions left this year, Edelweiss has given its final list of the stocks.

Analysts at Edelweiss believe that along with Gland Pharma, Yes Bank, Jubilant FoodWorks, Adani Enterprises, PI Industries, Hindustan Aero will be reclassified as large-cap stocks. Currently, all the abovementioned stocks are in the mid-cap category. So far, since listing, Gland Pharma’s share price has zoomed 35% and 64% from the issue price. Yes Bank’s share price is still down over 60% since January but the lender has shown signs of a turnaround after its successful reconstruction earlier this year.

Jubilant FoodWorks, the parent company of Domino’s Pizza in India has seen shares gain 64% since January. Adani Enterprises has zoomed 140% since the beginning of this year while PI Industries has gained 53% and Hindustan Aeronautics, despite a tumultuous year is still up 13%.

The report adds that Bank of Baroda, General Insurance Corporation of India, Concor India, United Breweries, MRF, and NMDC will be moved lower to the mid-cap segment from the current large-cap categorisation. General Insurance Corporation’s share price is down 37% so far this year as the stock failed to recover from March lows. Bank of Baroda is down 38%, while Concor is down 31%. Along with these, Edelweiss also expects Max Healthcare to be moved to the midcap category post demerger.

Stocks that may be reclassified as midcaps from the current smallcap category include those that have recently gained significantly. These include but are not limited to Laurus Labs, Indiamart Intermesh, Dixon Technologies, AstraZeneca Pharmaceuticals, among others. On the other hand, stocks that may move to the smallcap category include, Future Retail, PVR, Symphony, JM Financial, Apollo Tyres, Indiabulls Housing Finance, SKF India, Cholamandalam Finance, etc.

“The final/official list of Large, Mid and Small caps will be released by AMFI by 1st week of Jan-21, which will be effective for the Feb-21 to Jul-21 period. Indian Mutual funds will have to re-align the schemes within one month,” the report said. The review of companies based on market capitalization is done twice in a year — June and December. Largecap firms are the top 100 firms based on market capitalization, midcap firms are ranked from 101-250 while 251 onwards are smallcap firms.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

The Outlooker is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

The Outlooker Web Desk

The Outlooker Web Desk

Next Post
“Anybody Who Speaks Against BJP Faces ED, CBI”: Maharashtra Minister Anil Deshmukh

"Anybody Who Speaks Against BJP Faces ED, CBI": Maharashtra Minister Anil Deshmukh

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Amid Row, Congress Plans Month-Long Protests Against Centre
National

Amid Row, Congress Plans Month-Long Protests Against Centre

March 28, 2023
Gandhi Family Is Congress Pivot, Keeps Party United: Ashok Gehlot
National

Gandhi Family Is Congress Pivot, Keeps Party United: Ashok Gehlot

March 28, 2023
18 Pharma Companies To Lose Licenses Over Poor Quality Medicines: Sources
National

18 Pharma Companies To Lose Licenses Over Poor Quality Medicines: Sources

March 28, 2023
UP Gangster Atiq Ahmed Found Guilty In Kidnapping Case
National

UP Gangster Atiq Ahmed Found Guilty In Kidnapping Case

March 28, 2023

Connect with us

No Result
View All Result

Archives

  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Movie
  • Music
  • National
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • Amid Row, Congress Plans Month-Long Protests Against Centre
  • Gandhi Family Is Congress Pivot, Keeps Party United: Ashok Gehlot
  • 18 Pharma Companies To Lose Licenses Over Poor Quality Medicines: Sources

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.